Leslie Helou has been at Upsher-Smith for over 10 years. She has spent the majority of that time as the Therapeutic Lead for the Strategic Portfolio Management Group identifying, tracking trends, and selecting therapeutic areas for development and growth of Upsher-Smith’s neurology pipeline. She was responsible for identifying and selecting pipeline candidates in the areas of epilepsy, Parkinson’s, and cognition. Most recently, she served as the Program Lead for Upsher-Smith’s intranasal development program. Leslie began her career as a clinical research scientist gaining experience in NDA, ANDA, and consumer health products.